Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy

Introduction: Despite the recognized importance of atrophy in multiple sclerosis (MS), methods for its quantification have been mostly restricted to the research domain. Recently, a CE labelled and FDA approved MS-specific atrophy quantification method, MSmetrix, has become commercially available. H...

Full description

Bibliographic Details
Main Authors: Martijn D. Steenwijk, Houshang Amiri, Menno M. Schoonheim, Alexandra de Sitter, Frederik Barkhof, Petra J.W. Pouwels, Hugo Vrenken
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:NeuroImage: Clinical
Online Access:http://www.sciencedirect.com/science/article/pii/S2213158217301651